Alfred E. Brown

BCM Technologies Inc (BCM Technologies) is a venture capital subsidiary of Baylor University founded in 1983. The firm is headquartered in Houston, Texas.

Spectral Genomics is a biotechnology company that makes DNA microarrays and chips which can be used in cloning and genome profiling. Its arrays are made from bacterial artificial chromosomes (BACs). The company's Spectral Chip and Constitutional Chip are designed to highlight the genome's spots in research. The company supplies BAC clones to university laboratories and biotech and pharmaceutical research and development facilities. Spectral Genomics also sells the SpectralWare Array Analysis System, software designed for use in conjunction with the company's arrays. Spectral Genomics is headquartered in Houston, TX

Part of Innovaro, Inc., Knowledge Express Data Systems is a company that provides subscription access to a comprehensive information platform combining business development and technology resources. The company is based in King of Prussia, PA. The company was founded by Alfred E. Brown. Knowledge Express Data Systems was acquired by UTEK Corp. on July 11, 2005.

Oncovance Technologies, Inc. provides information management and analytical services and solutions to the healthcare industry. It provides database and information management to pharmaceutical and medical device manufacturers to promote and differentiate therapeutics, IT tools that improve and personalize treatment decisions & support physician users, and platforms to drive diagnostics development and sales. The company was founded by Kevin M. Slawin, Peter T. Scardino, and Michael W. Kattan and is headquartered in Houston, TX.

Kardia Therapeutics, Inc. develops cardiac regenerative therapies. It focuses in the areas of myocardial infarction and heart failure. The firm's portfolio of technologies utilizes three related approaches which include adult cardiac progenitor cells, stem cell optimization technologies, and homing/growth factor therapies. The company was founded by Michael D. Schneider and Robert J. Schwartz in 2002 and is headquartered in Houston, TX.

Molecular LogiX, Inc. develops new drugs based on human proteins. The company was founded by Daniel J. Monticello and Philip T. Pienkos in 2003 and is headquartered in Houston, TX.

Progression Therapeutics, Inc. develops prognostic tests and therapies for the treatment of cancer. Its products are used in the treatment of primary and metastatic cancer. The firm develops a tumor suppressor gene product that has demonstrated potent anti-tumor activity both in vitro and in vivo. The company was founded on December 27, 2001 and is headquartered in Houston, TX.